TG Therapeutics to Participate in the Jefferies Virtual London Healthcare Conference
Fireside chat scheduled for Tuesday, November 17, 2020 at 2:20 PM ET/ 7:20 PM GMT NEW YORK, Nov. 13, 2020...
Year: 2020
BioXcel Therapeutics to Participate in the Jefferies Virtual London Healthcare Conference
NEW HAVEN, Conn., Nov. 13, 2020 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BTI” or the “Company”) (Nasdaq: BTAI), a clinical-stage...
Sio Gene Therapies Announces Corporate Updates and Financial Results for Second Fiscal Quarter Ended September 30, 2020
Continued progress across pipeline of gene therapy programs, including recent IND clearance for AXO-AAV-GM2 in Tay-Sachs/Sandhoff diseases Completed rebranding to...
Oyster Point Pharma Announces Clinical Data Presentations on OC-01 Nasal Spray for Dry Eye Disease at the American Academy of Ophthalmology 2020 Virtual Annual Meeting
Results from the Phase 2 IMPERIAL study illustrate OC-01 nasal spray caused a decrease in goblet cell size, as compared...
BioCryst Presents New Data Highlighting Burden of Therapy with Current Injectable Prophylaxis Medication for HAE
—Data presented at the 2020 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)— RESEARCH TRIANGLE...
Prevail Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights
Patient Dosing Continues in the Phase 1/2 PROPEL Trial of PR001 for Parkinson’s Disease with GBA1 Mutations Phase 1/2 PROVIDE...
Medicenna Reports Second Quarter Fiscal 2021 Financial Results and Operational Highlights
TORONTO and HOUSTON, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. ("Medicenna" or “the Company") (NASDAQ: MDNA; TSX: MDNA), a...
RedHill Biopharma to Present at German Equity Forum 2020
TEL AVIV, Israel and RALEIGH, N.C., Nov. 13, 2020 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the...
Vistin Pharma ASA: Meldepliktig handel
Intertrade Shipping AS har i dag kjøpt 148 461 aksjer i Vistin Pharma ASA til gjennomsnittskurs 16,25 per aksje. Intertrade Shipping...
Madrigal Pharmaceuticals Highlights Presentations at The Liver Meeting Digital Experience™, The American Association for the Study of Liver Diseases Meeting November 13, 2020, Including NASH Expert Insights on the Ongoing Open Label Arm of Resmetirom 52-Week Phase 3 MAESTRO-NAFLD-1 Trial
Dr. Stephen Harrison will present Resmetirom for the Treatment of NASH: Early Data from the Phase 3 MAESTRO Clinical Trials...
Correction: Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, November 13, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) publishes corrected information about the following transactions...
ORIC Pharmaceuticals Announces Pricing of Upsized Public Offering
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 13, 2020 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage...
Shattuck Labs Reports Third Quarter 2020 Financial Results and Recent Business Highlights
– Initiated Phase 1 clinical trial for lead wholly owned CD47 checkpoint inhibitor, SL-172154 (SIRPα-Fc-CD40L), for the treatment of ovarian...
Lantheus Holdings Announces FDA Clearance for AI-Enabled Automated Bone Scan Index (aBSI) in Prostate Cancer on GE Healthcare’s Xeleris Platform
NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals,...
PQ Bypass Releases Positive 24-Month Data from the DETOUR1 Clinical Trial for Percutaneous Femoropopliteal Bypass at VIVA 2020
Promising long-term safety and effectiveness results from PAD population with extremely complex SFA disease MILPITAS, Calif.--(BUSINESS WIRE)--#ClinicalTrial--PQ Bypass, Inc, a...
LaVoieHealthScience Names James (Jim) Heins as Senior Vice President and Managing Director of its New York Practice
BOSTON & NEW YORK--(BUSINESS WIRE)--LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science...
Aytu BioScience Announces Fiscal Q1 2021 Net Revenue of $13.5 Million, an Increase of 839% Year-Over-Year
Q1 Consumer Health revenue reaches an all-time high of $7.8 million Live Conference Call and Webcast at 4:30 PM EST...
ReShape Lifesciences Announces Third Quarter 2020 Financial and Operational Results
SAN CLEMENTE, CA / ACCESSWIRE / November 12, 2020 / ReShape Lifesciences Inc. (OTCQB:RSLS), a global weight-loss solutions leader, today...
Lacerta Therapeutics Signs Gene Therapy Research Partnership with UCB
New research collaboration and licensing agreement with Lacerta provides UCB access to a novel gene therapy program and proprietary AAV...
StemoniX Announces Publication Demonstrating High-throughput Screening Using Human-derived CNS Models
MAPLE GROVE, MN and SAN DIEGO, CA / ACCESSWIRE / November 12, 2020 / StemoniX, Inc. announced the publication of...